Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:35 PM
Ignite Modification Date:
2025-12-24 @ 1:35 PM
NCT ID:
NCT00020995
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Diagnosis of adenocarcinoma of the prostate
* Previously untreated and on watchful waiting
* Medically able to receive dietary intervention
PATIENT CHARACTERISTICS:
Age:
* 40 to 80
Performance status:
* Not specified
Life expectancy:
* Not specified
Hematopoietic:
* Not specified
Hepatic:
* Not specified
Renal:
* Not specified
Other:
* Must be willing to travel to UCLA 3 days a week for 4 weeks to obtain specially prepared foods
PRIOR CONCURRENT THERAPY:
Biologic therapy:
* Not specified
Chemotherapy:
* Not specified
Endocrine therapy:
* No concurrent luteinizing hormone-releasing hormone agonists (leuprolide or goserelin)
* No concurrent androgen-receptor blocking agents (flutamide or bicalutamide)
* No concurrent testosterone
* No concurrent insulin
* No concurrent finasteride
Radiotherapy:
* Not specified
Surgery:
* No prior orchiectomy
Other:
* No concurrent saw palmetto supplement
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
40 Years
Maximum Age:
80 Years
Study:
NCT00020995
Study Brief:
Protocol Section:
NCT00020995